Health outcomes | Total sample (n = 3060) | Women (n = 1583, 52%) | Men (n = 1477, 48%) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RA | PSM | IV | RA | PSM | IV | RA | PSM | IV | ||||||||||
Coef | p | ATT | p | LATE | p | Coef | p | ATT | p | LATE | p | Coef | p | ATT | p | LATE | p | |
NCD morbidity | 0.12 | 0.411 | 0.029 | 0.480 | −0.146 | 0.499 | 0.26 | 0.126 | 0.029 | 0.052 | −0.672 | 0.447 | −0.04 | 0.633 | 0.004 | 0.904 | −0.013 | 0.950 |
Asthma | 0.19 | 0.410 | 0.008 | 0.383 | 0.070 | 0.502 | 0.69 | 0.018 | 0.023 | 0.002 | −0.118 | 0.729 | − 0.34 | 0.196 | − 0.007 | 0.171 | 0.146 | 0.196 |
Other lung diseases | 0.83 | 0.002 | 0.020 | 0.001 | 0.089 | 0.315 | 1.07 | 0.009 | 0.020 | 0.000 | − 0.019 | 0.940 | 0.63 | 0.103 | 0.013 | 0.064 | 0.111 | 0.262 |
Cancer, malignant tumours | −0.93 | 0.050 | − 0.004 | 0.082 | − 0.084 | 0.123 | − 0.95 | 0.142 | − 0.006 | 0.179 | − 0.165 | 0.424 | −0.87 | 0.213 | −0.006 | 0.234 | −0.062 | 0.224 |
Diabetes | −0.04 | 0.296 | 0.004 | 0.370 | 0.078 | 0.590 | 0.04 | 0.517 | 0.006 | 0.882 | 0.389 | 0.478 | −0.13 | 0.357 | 0.010 | 0.985 | −0.039 | 0.792 |
Cardiovascular diseases | 0.34 | 0.048 | 0.018 | 0.134 | −0.114 | 0.362 | 0.27 | 0.177 | 0.014 | 0.104 | −0.165 | 0.669 | 0.43 | 0.128 | 0.016 | 0.224 | −0.103 | 0.427 |
Stroke | 0.05 | 0.844 | −0.001 | 0.862 | −0.019 | 0.829 | −0.09 | 0.859 | −0.001 | 0.805 | −0.538 | 0.309 | 0.12 | 0.774 | −0.009 | 0.605 | 0.129 | 0.223 |
HbA1c levels | −0.10 | 0.988 | 0.041 | 0.837 | 0.842 | 0.829 | 0.18 | 0.970 | 0.060 | 0.732 | −1.202 | 0.492 | 0.04 | 0.972 | −0.030 | 0.770 | 0.052 | 0.927 |
Hypertension | 0.03 | 0.155 | 0.004 | 0.115 | 0.466 | 0.138 | −0.08 | 0.594 | −0.025 | 0.914 | 0.981 | 0.408 | 0.12 | 0.232 | 0.026 | 0.201 | 0.301 | 0.331 |
CRP levels | −0.21 | 0.063 | −0.131 | 0.002 | 1.908 | 0.746 | −0.09 | 0.247 | −0.152 | 0.011 | −1.249 | 0.480 | −0.32 | 0.192 | −0.065 | 0.214 | 0.088 | 0.351 |
Grip strengths | 0.19 | 0.364 | 0.330 | 0.068 | −2.959 | 0.370 | 0.07 | 0.806 | −0.260 | 0.890 | −6.162 | 0.524 | 0.38 | 0.246 | 0.464 | 0.326 | −2.099 | 0.578 |
Arthritis/rheumatism | −0.02 | 0.808 | −0.009 | 0.695 | −0.359 | 0.113 | −0.05 | 0.717 | 0.003 | 0.739 | −1.061 | 0.350 | 0.07 | 0.910 | 0.008 | 0.627 | −0.177 | 0.343 |
Sensory impairments | −0.09 | 0.576 | −0.005 | 0.660 | 0.107 | 0.563 | −0.12 | 0.531 | −0.023 | 0.271 | 0.564 | 0.455 | −0.04 | 0.990 | −0.010 | 0.740 | 0.014 | 0.938 |
Upper-body functional limitations | 0.17 | 0.014 | 0.041 | 0.011 | −0.431 | 0.157 | 0.24 | 0.004 | 0.074 | 0.016 | −1.261 | 0.380 | 0.18 | 0.199 | 0.032 | 0.364 | −0.208 | 0.427 |
Lower-body functional limitations | 0.12 | 0.166 | 0.047 | 0.133 | −0.195 | 0.492 | 0.27 | 0.016 | 0.073 | 0.004 | −0.450 | 0.643 | −0.07 | 0.487 | 0.004 | 0.854 | −0.163 | 0.551 |
Episodic memory | 0.09 | 0.062 | 0.112 | 0.206 | 5.144 | 0.002 | 0.06 | 0.283 | 0.043 | 0.523 | 6.404 | 0.051 | 0.12 | 0.130 | 0.070 | 0.207 | 4.175 | 0.020 |
Visuospatial abilities | −0.04 | 0.967 | −0.035 | 0.855 | 6.199 | 0.003 | −0.12 | 0.266 | −0.080 | 0.465 | 4.983 | 0.028 | 0.08 | 0.208 | 0.063 | 0.193 | 7.728 | 0.058 |
ADL limitations | 0.19 | 0.000 | 0.187 | 0.000 | −0.532 | 0.501 | 0.26 | 0.000 | 0.220 | 0.000 | −5.053 | 0.334 | 0.10 | 0.112 | 0.177 | 0.011 | 0.842 | 0.270 |
IADL limitations | 0.56 | 0.000 | 0.500 | 0.003 | −4.283 | 0.096 | 0.66 | 0.000 | 0.473 | 0.000 | −13.602 | 0.327 | 0.39 | 0.050 | 0.492 | 0.033 | −1.812 | 0.432 |